Harvard Bioscience, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2025
Total Assets: $80.1M
Liabilities Breakdown FY2025
Total Liabilities: $66.3M
Asset Breakdown
Total Assets: $80.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $8.6M | 10.8% |
| Accounts Receivable | $16.0M | 20.0% |
| Inventory | $20.8M | 26.0% |
| Property, Plant & Equipment | $4.8M | 6.0% |
| Goodwill | $9.6M | 11.9% |
| Intangible Assets | $7.6M | 9.5% |
| Other Assets | $12.6M | 15.8% |
Liabilities Breakdown
Total Liabilities: $66.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.7M | 5.5% |
| Long-Term Debt | $35.9M | 54.1% |
| Other Liabilities | $26.8M | 40.4% |